Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-14-058440
Filing Date
2014-09-29
Accepted
2014-09-29 17:00:37
Documents
5
Period of Report
2014-11-10

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A v390196_pre14a.htm PRE 14A 572873
2 GRAPHIC tlogo.jpg GRAPHIC 10707
3 GRAPHIC tsig.jpg GRAPHIC 5051
4 GRAPHIC image_002.gif GRAPHIC 95091
5 GRAPHIC image_004.gif GRAPHIC 24400
  Complete submission text file 0001144204-14-058440.txt   761015
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 141127499
SIC: 2836 Biological Products, (No Diagnostic Substances)